Peptide record

TPDB45203

Antiviral standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45203
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 17-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
CYGSKNTGAKKRKIDDA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C77H131N25O26S1
EQHLMFPWV
K
1855.10
9.97
5
2
4
+3
3.27
-1.388
34.71
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
1490
0.80
5
Residue Composition
number
2
A
1
R
1
N
2
D
1
C
0
E
0
Q
2
G
0
H
1
I
0
L
4
K
0
M
0
F
0
P
1
S
1
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 2 R: 1 N: 1 D: 2 C: 1 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 0 K: 4 M: 0 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 1 V: 0
Chemical Descriptors
17 reviewed residue count
C77H131N25O26S1 sequence-only estimate (linear, free termini)
1855.10 sequence-only estimate (linear, free termini)
9.97 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
3.27 sequence-only estimate (linear, free termini)
-1.388 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA